Axon’s Covid-19 vaccine shows significant effect in pre-clinical study

This article was originally published here

The company has reported positive pre-clinical results and confirmed the efficacy of the vaccine on the live SARS CoV-2 virus. ACvac1 is a prophylactic COVID-19 vaccine designed to

The post Axon’s Covid-19 vaccine shows significant effect in pre-clinical study appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply